Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY:BMY)

59.67 -0.68 (-1.13%)
Streaming Delayed Price Updated: 11:55 AM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bristol-Myers Squibb

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
86 87 Next >
News headline image
Crude Oil Down Over 2%; Bristol Myers Squibb Posts Upbeat Q2 Results ↗
 
Via Benzinga
News headline image
BMY Stock Earnings: Bristol-Myers Squibb Beats EPS, Beats Revenue for Q2 2024 ↗
BMY stock results show that Bristol-Myers Squibb beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Norfolk Southern Posts Upbeat Earnings, Joins Newell Brands, Charter Communications, 3M And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
Bristol Myers Squibb Witnesses Strong Demand For 'Newer Drugs' As Q2 Earnings Beat Expectations, Raises 2024 Profit Forecast ↗
Bristol Myers Squibb reported Q2 revenues of $12.2 billion, surpassing the consensus of $11.55B, driven by its Growth Portfolio and Eliquis. The company's adjusted EPS of $2.07 beat expectations of... 
Via Benzinga
Topics Earnings
News headline image
Bristol Myers Squibb Earnings Easily Beat On Cost Cuts; Stock Jumps ↗
The drug giant also raised guidance. 
Via Investor's Business Daily
News headline image
A Glimpse Into The Expert Outlook On Bristol-Myers Squibb Through 4 Analysts ↗
 
Via Benzinga
News headline image
US Stocks Look To End Week On High Note As Nvidia Leads Mega-Caps Higher In Premarket Ahead Of Key Inflation Data ↗
After the severe pounding the tech space received in the past three sessions, it might be rebound time. However, any recovery will largely hinge on whether key inflation data confirms the continued... 
Via Benzinga
Topics Economy
News headline image
Bristol Myers Squibb Reports Second Quarter Financial Results for 2024
From Bristol Myers Squibb
Via Business Wire
News headline image
S&P 500, Nasdaq Settle Lower As Tech Stocks Continue To Falter: Greed Index In 'Fear' Zone ↗
 
Via Benzinga
Topics Stocks
News headline image
What the Options Market Tells Us About Bristol-Myers Squibb ↗
 
Via Benzinga
News headline image
High Dividend 50: Bristol-Myers Squibb ↗
This article will examine the prospects of Bristol-Myers as an investment opportunity. 
Via Talk Markets
News headline image
Bristol-Myers Squibb Unusual Options Activity For July 15 ↗
 
Via Benzinga
News headline image
Bristol-Myers Squibb, Deckers Outdoor And 3 Stocks To Watch Heading Into Friday ↗
 
Via Benzinga
News headline image
DECK, SKX Higher After Earnings; PCE On Tap Friday ↗
It’s tough to get a firm handle on this market. One day it looks like a trading rotation into undervalued equities from big run-ups elsewhere, the next day it’s a major selloff across the board. 
Via Talk Markets
News headline image
2 High-Yield Dividend Stocks Billionaires Are Buying. Are They Right for You? ↗
Billionaires are buying these stocks, but that doesn't necessarily make them right for your portfolio. 
Via The Motley Fool
News headline image
Newly-Listed Psoriasis-Focused Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation ↗
Guggenheim Partners initiated coverage on Alumis, highlighting its lead asset ESK-001, a TYK2 inhibitor for plaque psoriasis and systemic lupus erythematosus. With upcoming Phase 3 trials and no JAK... 
Via Benzinga
News headline image
Microsoft To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday ↗
 
Via Benzinga
News headline image
AstraZeneca, Sanofi And Other Pharma Giants Pursue Chinese Deals Despite Rising US-China Strife ↗
The aim is to strengthen their drug pipelines and expand their presence in the world's second-largest pharmaceutical market. 
Via Benzinga
News headline image
3 Defensive Stocks to Shield Your Portfolio in July ↗
Fed Chair Jerome Powell’s cautious economic outlook adds to the allure of defensive stocks offering stable long-term returns 
Via InvestorPlace
Topics Economy
News headline image
7 Value Stocks to Buy at a 52-Week Low in July ↗
Bottom fishers and contrarians take note: each of these seven value stocks to buy is on sale after recently hitting new 52-week lows. 
Via InvestorPlace
News headline image
Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review ↗
The Nasdaq tumbled amid chip woes. 
Via Investor's Business Daily
News headline image
Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally ↗
The earnings parade continues this week with a slightly accelerated tempo as analysts brace for a healthy reporting season. 
Via Benzinga
News headline image
Bristol Myers Squibb Receives European Medicines Agency Validation of Application for Opdivo (nivolumab) plus Yervoy (ipilimumab) for First-Line Treatment of Unresectable or Advanced Hepatocellular Carcinoma
From Bristol Myers Squibb
Via Business Wire
News headline image
Collect $2,000 in Dividends Per Year by Investing $35,000 in These 3 Stocks ↗
These stocks all pay more than four times the S&P 500 average. 
Via The Motley Fool
Topics Stocks
News headline image
US Bancorp Posts Upbeat Earnings, Joins Aehr Test Systems, Hancock Whitney And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings' ↗
 
Via Benzinga
Topics Bankruptcy
News headline image
Got $500? 2 No-Brainer Growth Stocks to Buy and Hold Forever ↗
These businesses are begging to be bought. 
Via The Motley Fool
News headline image
Week In Review: Foreseen Sells ADC Rights To France's Ipsen In $1 Billion Deal ↗
In other news, Sichuan Biokin Pharma has filed for an IPO on the Hong Kong Exchange; more on the Biosecure Act being pushed by US Speaker of the House Johnson. 
Via Talk Markets
Topics Initial Public Offering
News headline image
3 High-Yielding Dividend Stocks Near Their 52-Week Lows ↗
These stocks all yield more than 3%. 
Via The Motley Fool
News headline image
2 Pharma Stocks to Buy Hand Over Fist This Month ↗
These drugmakers may not be in perfect health right now, but that shouldn't last much longer. 
Via The Motley Fool
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
86 87 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.